Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Jan 20, 2026 · Filed Jan 21, 2026
A board member of Gilead Sciences sold $618K of Gilead Sciences shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$617,500
Shares × reported transaction price
82 days after results of Oct 30, 2025, 21 days before results of Feb 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $124.14 on Jan 20, 2026, within 4% of its 52-week high, after a 1% rise over the previous 30 trading days
52-week range $92.92 (Jan 23, 2025) to $128.07 (Nov 19, 2025), 89% of the way up, from 251 adjusted closes. 30 trading days earlier: $122.62 on Dec 4, 2025. Describes the past only, not a forecast
A WARN layoff notice covering 34 workers was filed in California on January 21, 2026.
From the official state WARN list, 1 day after the trade. Shown for timing only; the two filings are separate
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.4% | +0.7% | +5.7% |
| 30 days | +14.3% | -1.0% | +15.2% |
| 90 days | +1.3% | +3.2% | -1.9% |
| 180 days | -0.7% | +8.6% | -9.3% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$2.84M of Gilead Sciences
Scheduled in advanceOfficer sold ~$1.46M of Gilead Sciences
Scheduled in advance